We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharma's Prospects Rise in 2005 With Promising New Drugs, S&P Says
Pharma's Prospects Rise in 2005 With Promising New Drugs, S&P Says
March 4, 2005
While the pharmaceutical industry has taken a hit for its lackluster pipeline in recent years, there are a number of promising products -- either newly approved or soon-to-be-approved -- that could give big pharma firms a boost in 2005 and beyond, according to a new research report from Standard & Poor's (S&P).